AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16988120 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 egg per day for 5 weeks
Number of subjects: 33
Study 16988120 — intervention group
Group type: COMPARATOR
Intervention: Egg substitute per day for 5 weeks
Number of subjects: 33
Study 14673683 — intervention group
Group type: EXPERIMENTAL
Intervention: Th2‐3 ETS
Number of subjects: 25
Study 14673683 — intervention group
Group type: EXPERIMENTAL
Intervention: Th2‐4 ETS
Number of subjects: 25
Study 10731537 — intervention group
Group type: EXPERIMENTAL
Intervention: IUI and FT-ET with ovulation induction (Clomiphene citrate and hCG)
Number of subjects: 62
Study 10731537 — intervention group
Group type: COMPARATOR
Intervention: FT-ET with ovulation induction (Clomiphene citrate and hCG)
Number of subjects: 62
Study 9187886 — intervention group
Group type: EXPERIMENTAL
Intervention: Aflurax 1200 mg, two tablets four times daily
Number of subjects: 102
Study 9187886 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study 8237844 — intervention group
Group type: COMPARATOR
Intervention: Whole cow milk plus iron-fortified cereal (WCM + C)
Number of subjects: 104
Study 8237844 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-fortified follow-up formulas
Number of subjects: 104
Study 8237844 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-fortified infant formula
Number of subjects: 104
Study 3888886 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 18
Study 3888886 — intervention group
Group type: COMPARATOR
Intervention: Lactose (Control)
Number of subjects: 18
Study 31539086 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-directed learning digital tool
Number of subjects: 27
Study 31539086 — intervention group
Group type: COMPARATOR
Intervention: Tutorials under the guidance of an educator
Number of subjects: 27
Study 29554032 — intervention group
Group type: EXPERIMENTAL
Intervention: Meloxicam IV 30 mg
Number of subjects: 201
Study 29554032 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 201
Study 26716734 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused-Breathing Strategy (FBS)
Number of subjects: 82
Study 26716734 — intervention group
Group type: COMPARATOR
Intervention: Focused-Distraction Strategy (FDS)
Number of subjects: 82
Study 24651151 — intervention group
Group type: EXPERIMENTAL
Intervention: BoNT‐A injection of the Rectus Femoris (RF) muscle
Number of subjects: 14
Study 22222102 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak flow monitoring during a 16-week asthma self-management program
Number of subjects: 77
Study 22222102 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak flow monitoring
Number of subjects: 77
Study 20299336 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual exposure to cyclosporine (n = 101)
Number of subjects: 212
Study 20299336 — intervention group
Group type: EXPERIMENTAL
Intervention: Low exposure to cyclosporine (n = 106)
Number of subjects: 212
Study 20299336 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual exposure to cyclosporine
Number of subjects: 212
Study 20299336 — intervention group
Group type: EXPERIMENTAL
Intervention: Low exposure to cyclosporine
Number of subjects: 212
Study 17998023 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (200 mg taken twice a day for 7 days)
Number of subjects: 16
Study 17998023 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 15824911 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciclesonide via hydrofluoroalkane metered-dose inhaler
Number of subjects: 18
Study 15824911 — intervention group
Group type: COMPARATOR
Intervention: Budesonide via chlorofluorocarbon metered-dose inhaler
Number of subjects: 18
Study 15824911 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciclesonide
Number of subjects: 18
Study 15824911 — intervention group
Group type: EXPERIMENTAL
Intervention: Des-CIC
Number of subjects: 18
Study 12496745 — intervention group
Group type: EXPERIMENTAL
Intervention: Irinotecan (100-340 mg/m²)
Number of subjects: 78
Study 12496745 — intervention group
Group type: EXPERIMENTAL
Intervention: SN-38 and SN-38 glucuronide (SN-38G)
Number of subjects: 78
Study 9800929 — intervention group
Group type: EXPERIMENTAL
Intervention: Uterine exteriorisation
Number of subjects: 194
Study 9800929 — intervention group
Group type: COMPARATOR
Intervention: In situ repair
Number of subjects: 194
Study 8587687 — intervention group
Group type: EXPERIMENTAL
Intervention: Microsurgical resection
Number of subjects: 32
Study 8587687 — intervention group
Group type: EXPERIMENTAL
Intervention: Microsurgical resection with preoperative transfemoral embolization
Number of subjects: 32
Study 8587687 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiosurgery for residual AVMs
Number of subjects: 32
Study 8587687 — intervention group
Group type: EXPERIMENTAL
Intervention: Embolization followed by radiosurgery for surgically inaccessible AVMs
Number of subjects: 32
Study 8587687 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment approach
Number of subjects: 32
Study 2501104 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (20 mg)
Number of subjects: 10
Study 2501104 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (20 mg)
Number of subjects: 10
Study 2501104 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of nifedipine and sodium cromoglycate
Number of subjects: 10
Study 29444707 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic retrograde cholangiography (ERC)
Number of subjects: 184
Study 29444707 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous transhepatic biliary drainage (PTBD)
Number of subjects: 184
Study 26516142 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic statin therapy
Number of subjects: 5000
Study 26516142 — intervention group
Group type: COMPARATOR
Intervention: Adjuvanted and unadjuvanted vaccine groups
Number of subjects: 5000
Study 24810369 — intervention group
Group type: EXPERIMENTAL
Intervention: elosulfase alfa 2.0 mg/kg/week
Number of subjects: 176
Study 24810369 — intervention group
Group type: EXPERIMENTAL
Intervention: elosulfase alfa 2.0 mg/kg/every other week (qow)
Number of subjects: 176
Study 24810369 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 176
Study 23573238 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced glycerin formulation of tenofovir 1% gel
Number of subjects: 65
Study 23573238 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyethyl cellulose placebo gel
Number of subjects: 65
Study 23573238 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonoxynol‐9 gel
Number of subjects: 65
Study 23573238 — intervention group
Group type: COMPARATOR
Intervention: Fecal calprotectin, rectal microflora, and epithelial sloughing
Number of subjects: 65
Study 23573238 — intervention group
Group type: COMPARATOR
Intervention: Histology, mucosal gene expression, protein expression, and T cell phenotype
Number of subjects: 65
Study 30148449 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% sodium citrate
Number of subjects: 210
Study 30148449 — intervention group
Group type: COMPARATOR
Intervention: Heparin 5,000 µ/mL
Number of subjects: 210
Study 18444147 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 servings/day of vegetables and fruit (VF)
Number of subjects: 64
Study 18444147 — intervention group
Group type: COMPARATOR
Intervention: 2 servings/day of vegetables and fruit (VF)
Number of subjects: 64
Study 18444147 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 servings/day of vegetables and fruit (VF)
Number of subjects: 64
Study 16540291 — intervention group
Group type: EXPERIMENTAL
Intervention: Delusional patients
Number of subjects: 3
Study 16540291 — intervention group
Group type: COMPARATOR
Intervention: Non-delusional patients
Number of subjects: 3
Study 16540291 — intervention group
Group type: COMPARATOR
Intervention: Healthy participants
Number of subjects: 3
Study 14517193 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxidectin (MOX) 3 mg
Number of subjects: 24
Study 14517193 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxidectin (MOX) 9 mg
Number of subjects: 24
Study 14517193 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxidectin (MOX) 18 mg
Number of subjects: 24
Study 14517193 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxidectin (MOX) 36 mg
Number of subjects: 24
Study 14517193 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxidectin (MOX) with high-fat breakfast (9 mg)
Number of subjects: 24
Study 14517193 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxidectin (MOX) with high-fat breakfast (36 mg)
Number of subjects: 24
Study 14517193 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 10863679 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback treatment
Number of subjects: 94
Study 10863679 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral skills training (CBST) treatment
Number of subjects: 94
Study 10863679 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined (biofeedback/CBST) treatment
Number of subjects: 94
Study 10863679 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 94
Study 9483717 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 0
Study 9483717 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9483717 — intervention group
Group type: EXPERIMENTAL
Intervention: Segments influenced by PTCA
Number of subjects: 0
Study 9483717 — intervention group
Group type: COMPARATOR
Intervention: Segments not influenced by PTCA
Number of subjects: 0
Study 9483717 — intervention group
Group type: EXPERIMENTAL
Intervention: Segments influenced by CABG
Number of subjects: 0
Study 9483717 — intervention group
Group type: COMPARATOR
Intervention: Segments not influenced by CABG
Number of subjects: 0
Study 9483717 — intervention group
Group type: EXPERIMENTAL
Intervention: Existing lesions proximal to bypass anastomosis
Number of subjects: 0
Study 9483717 — intervention group
Group type: COMPARATOR
Intervention: Existing lesions not proximal to bypass anastomosis
Number of subjects: 0
Study 1440167 — intervention group
Group type: COMPARATOR
Intervention: Single drain (one catheter in the axilla and one catheter under the inferior flap for modified radical mastectomy)
Number of subjects: 65
Study 1440167 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple drains (four catheters in the axilla for axillary dissection; four catheters in the axilla and one under the inferior flap for modified radical mastectomy)
Number of subjects: 65
Study 3515927 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen (50 mg)
Number of subjects: 159
Study 3515927 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (650 mg)
Number of subjects: 159
Study 3515927 — intervention group
Group type: EXPERIMENTAL
Intervention: Codeine (60 or 120 mg)
Number of subjects: 159
Study 3515927 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 159
Study 31712969 — intervention group
Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine (NAC) 2400 mg daily for 12 weeks
Number of subjects: 302
Study 31712969 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 302
Study 31712969 — intervention group
Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine (NAC)
Number of subjects: 302
Study 29734488 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality Exposure (VRE)
Number of subjects: 108
Study 29734488 — intervention group
Group type: COMPARATOR
Intervention: Prolonged Exposure (PE)
Number of subjects: 108
Study 29901322 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant stanol ester (Staest) intake
Number of subjects: 113
Study 29901322 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant stanol ester (Staest) intake with meal
Number of subjects: 113
Study 29901322 — intervention group
Group type: COMPARATOR
Intervention: Other mutations (control group)
Number of subjects: 113
Study 24901900 — intervention group
Group type: EXPERIMENTAL
Intervention: Bite Back (n=120)
Number of subjects: 235
Study 24901900 — intervention group
Group type: COMPARATOR
Intervention: Control websites (n=115)
Number of subjects: 235
Study 22429760 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 5 mg once a day (OaD)
Number of subjects: 378
Study 22429760 — intervention group
Group type: COMPARATOR
Intervention: Tadalafil 20 mg as needed (PRN)
Number of subjects: 378
Study 22429760 — intervention group
Group type: COMPARATOR
Intervention: Sildenafil 100 mg as needed (PRN)
Number of subjects: 378
Study 20411444 — intervention group
Group type: EXPERIMENTAL
Intervention: Supreme laryngeal mask airway (SLMA)
Number of subjects: 60
Study 20411444 — intervention group
Group type: COMPARATOR
Intervention: Proseal laryngeal mask airway (PLMA)
Number of subjects: 60
Study 18339360 — intervention group
Group type: EXPERIMENTAL
Intervention: TPA023B (1.5 mg)
Number of subjects: 4
Study 18339360 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study 16793612 — intervention group
Group type: EXPERIMENTAL
Intervention: ANH (Acute Normovolemic Hemodilution)
Number of subjects: 30
Study 16793612 — intervention group
Group type: EXPERIMENTAL
Intervention: ANH combined with controlled hypotension
Number of subjects: 30
Study 16793612 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine blood transfusion and fluid infusion)
Number of subjects: 30
Study 12735161 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone/bupivacaine
Number of subjects: 21
Study 12735161 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 21
Study 10669060 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive increase in magnitude of reinforcement for abstinence with a reset contingency for drug use
Number of subjects: 18
Study 10669060 — intervention group
Group type: COMPARATOR
Intervention: Fixed magnitude of reinforcement for abstinence
Number of subjects: 18
Study 10669060 — intervention group
Group type: COMPARATOR
Intervention: Progressive increase in magnitude of reinforcement for abstinence without a reset contingency
Number of subjects: 18
Study 9191764 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan (6 mg subcutaneous)
Number of subjects: 19
Study 9191764 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 1587064 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg proguanil alone
Number of subjects: 24
Study 1587064 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg proguanil with 100 mg racemic mephenytoin
Number of subjects: 24
Study 1587064 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg proguanil with 40 mg dextromethorphan
Number of subjects: 24
Study 1587064 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg racemic mephenytoin alone
Number of subjects: 24
Study 1587064 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg racemic mephenytoin with 200 mg proguanil
Number of subjects: 24
Study 1587064 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan metabolic ratio included in the model
Number of subjects: 24
Study 3516017 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% glucose in 0.9% sodium chloride solution (G)
Number of subjects: 16
Study 3516017 — intervention group
Group type: COMPARATOR
Intervention: 0.9% sodium chloride solution (S)
Number of subjects: 16
Study 31970448 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body vibration (WBV) training, five times per week
Number of subjects: 71
Study 31970448 — intervention group
Group type: COMPARATOR
Intervention: Mobilization exercises (active control group)
Number of subjects: 71
Study 30199423 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma (PRP)
Number of subjects: 0
Study 30199423 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium Hyaluronate (SH) + Platelet-Rich Plasma (PRP)
Number of subjects: 0
Study 30199423 — intervention group
Group type: COMPARATOR
Intervention: Sodium Hyaluronate (SH)
Number of subjects: 0
Study 30199423 — intervention group
Group type: COMPARATOR
Intervention: Normal Saline (Control)
Number of subjects: 0
Study 28835354 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet self-completion group (n=840)
Number of subjects: 1680
Study 28835354 — intervention group
Group type: COMPARATOR
Intervention: Telephone interview group (n=840)
Number of subjects: 1680
Study 26109727 — intervention group
Group type: EXPERIMENTAL
Intervention: DC-HIV-1 (dendritic cells pulsed with autologous HIV-1)
Number of subjects: 36
Study 26109727 — intervention group
Group type: COMPARATOR
Intervention: DC-control (nonpulsed dendritic cells)
Number of subjects: 36
Study 26109727 — intervention group
Group type: EXPERIMENTAL
Intervention: DC-HIV-1
Number of subjects: 36
Study 26109727 — intervention group
Group type: COMPARATOR
Intervention: DC-control
Number of subjects: 36
Study 22634831 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel patient-centred communication tool
Number of subjects: 146
Study 22634831 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard communication)
Number of subjects: 146
Study 21641663 — intervention group
Group type: EXPERIMENTAL
Intervention: Acamprosate
Number of subjects: 30
Study 21641663 — intervention group
Group type: EXPERIMENTAL
Intervention: Antipsychotics and anticonvulsants
Number of subjects: 30
Study 21641663 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticonvulsants and benzodiazepines
Number of subjects: 30
Study 21641663 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressants
Number of subjects: 30
Study 21641663 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 30
Study 19701845 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotretinoin therapy
Number of subjects: 50
Study 19701845 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers (Control)
Number of subjects: 50
Study 17050770 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral plus medical intervention
Number of subjects: 21
Study 17050770 — intervention group
Group type: COMPARATOR
Intervention: Medical intervention alone
Number of subjects: 21
Study 14977656 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic drilling with remaining cartilage (group A)
Number of subjects: 69
Study 14977656 — intervention group
Group type: COMPARATOR
Intervention: Arthroscopic drilling with removal of remaining cartilage (group B)
Number of subjects: 69
Study 11732953 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral dexamethasone (0.6 mg/kg)
Number of subjects: 264
Study 11732953 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized dexamethasone sodium phosphate (160 microg)
Number of subjects: 264
Study 11732953 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 264
Study 9640079 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin therapy
Number of subjects: 57
Study 9640079 — intervention group
Group type: EXPERIMENTAL
Intervention: IHD with HLP without aspirin
Number of subjects: 57
Study 9640079 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 57
Study 8477302 — intervention group
Group type: EXPERIMENTAL
Intervention: Preload intervention for restrained eaters
Number of subjects: 0
Study 8477302 — intervention group
Group type: EXPERIMENTAL
Intervention: High restrainers
Number of subjects: 0
Study 8477302 — intervention group
Group type: EXPERIMENTAL
Intervention: Link between dietary restraint and overeating
Number of subjects: 0
Study 2868207 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous hydrocortisone in addition to high-dose oral prednisolone and standard bronchodilator therapy
Number of subjects: 52
Study 2868207 — intervention group
Group type: COMPARATOR
Intervention: High-dose oral prednisolone and standard bronchodilator therapy
Number of subjects: 52
Study 29569793 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep hygiene and progressive relaxation exercise training
Number of subjects: 161
Study 29569793 — intervention group
Group type: COMPARATOR
Intervention: Routine health care (Control)
Number of subjects: 161
Study 27683869 — intervention group
Group type: EXPERIMENTAL
Intervention: SNAP-Ed intervention (first 4 curriculum lessons)
Number of subjects: 575
Study 27683869 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 575
Study 24582042 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodixanol-320 at 5.0 mL/sec flow rate (group 3)
Number of subjects: 254
Study 24582042 — intervention group
Group type: COMPARATOR
Intervention: Iodixanol-320 at 6.2 mL/sec flow rate (group 2)
Number of subjects: 254
Study 24582042 — intervention group
Group type: COMPARATOR
Intervention: Iomeprol-400 at 5.0 mL/sec flow rate (group 1)
Number of subjects: 254
Study 22483976 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralipid 40 mL/h
Number of subjects: 12
Study 22483976 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextrose 10% 40 mL/h
Number of subjects: 12
Study 22483976 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Intralipid and dextrose
Number of subjects: 12
Study 22483976 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 12
Study 22483976 — intervention group
Group type: COMPARATOR
Intervention: Dextrose
Number of subjects: 12
Study 21266737 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat acclimation (ACC) group
Number of subjects: 12
Study 21266737 — intervention group
Group type: COMPARATOR
Intervention: Control (CON) group
Number of subjects: 12
Study 21266737 — intervention group
Group type: COMPARATOR
Intervention: Both ACC and CON groups
Number of subjects: 12
Study 18767339 — intervention group
Group type: EXPERIMENTAL
Intervention: Home and Community Care team intervention
Number of subjects: 0
Study 18767339 — intervention group
Group type: EXPERIMENTAL
Intervention: Participatory research
Number of subjects: 0
Study 16471186 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 60
Study 11949774 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone 20 mg
Number of subjects: 16
Study 11949774 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 10051257 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral bambuterol 20 mg once daily in the evening
Number of subjects: 126
Study 10051257 — intervention group
Group type: COMPARATOR
Intervention: Inhaled salmeterol 50 micrograms twice daily
Number of subjects: 126
Study 10051257 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 126
Study 7676165 — intervention group
Group type: COMPARATOR
Intervention: Rechtschaffen and Kales criteria
Number of subjects: 55
Study 2288326 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acids L-tryptophan and L-tyrosine
Number of subjects: 29